Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study
Authors:
Open Access
- 6 December 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 79, 102984
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 19 references indexed in Scilit:
- Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaNew England Journal of Medicine, 2025
- Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is NowJournal of Clinical Oncology, 2023
- Adrenal insufficiencyNature Reviews Disease Primers, 2021
- Adrenal insufficiencyThe Lancet, 2021
- Adrenal CrisisNew England Journal of Medicine, 2019
- Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapyPituitary, 2018
- Endocrine Toxicity of Cancer Immunotherapy Targeting Immune CheckpointsEndocrine Reviews, 2018
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor RegimensJAMA Oncology, 2018
- Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapyClinical Endocrinology, 2014
- Assessment of Corticosteroid Replacement Therapy in Adults with Adrenal InsufficiencyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1999